TrialMolecular therapy : the journal of the American Society of Gene Therapy2024

Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A.

Brian R Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.